J 2020

Lycopene increases metabolic activity of rat liver CYP2B, CYP2D and CYP3A.

NOSKOVÁ, Kristýna; Gabriela PŘIBYL DOVRTĚLOVÁ; Ondřej ZENDULKA; Markéta STRAKOŠOVÁ; Ondřej PEŠ et al.

Basic information

Original name

Lycopene increases metabolic activity of rat liver CYP2B, CYP2D and CYP3A.

Edition

Pharmacological Reports, Heidelberg, Springer, 2020, 1734-1140

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Germany

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 3.027

Marked to be transferred to RIV

Yes

RIV identification code

RIV/00216224:14110/20:00115263

Organization unit

Faculty of Medicine

EID Scopus

Keywords in English

Lycopene; Rat; Cytochrome; P450; CYP3A; Induction

Tags

International impact, Reviewed
Changed: 4/3/2021 12:17, Mgr. Tereza Miškechová

Abstract

In the original language

Lycopene as a naturally occurring carotenoid is a common part of the human diet. Several beneficial properties of lycopene have been identified, with the most studied being anti-cancer and antioxidant activity. However, no evidence of possible drug–drug or drug–food supplement interactions has been found. We studied the in vivo effect of lycopene on the selected rat liver cytochromes P450 (CYPs): CYP1A2, CYP2B, CYP2C11, CYP2C6, CYP2D, and CYP3A. Lycopene was administered to rats intragastrically at doses of 4, 20, and 100 mg/kg/day for 10 consecutive days. Total protein content, P450 Content, and metabolic activity of selected CYPs were evaluated in the rat liver microsomal fraction. Increased CYP2B, CYP2D, and CYP3A metabolic activities were observed in animals treated with the lycopene dose of 100 mg/kg/day. The content of CYP3A1 protein was increased by the dose of 100 mg/kg/day and CYP3A2 protein was increased by all administered doses of lycopene. The results of our study indicate that lycopene increased the metabolic activity of enzymes that are orthologues to the most clinically important human enzymes involved in xenobiotic metabolism. The risk of pharmacokinetic interactions between lycopene dietary supplements and co-administered drugs should be evaluated.

Links

MUNI/A/0976/2018, interní kód MU
Name: Příspěvek chemických a biochemických metodik ke studiu molekulární podstaty vybraných patologických stavů a onemocnění
Investor: Masaryk University, Category A
MUNI/A/1167/2019, interní kód MU
Name: Příspěvek (bio)chemických technik ke studiu molekulární podstaty vybraných patologických jevů a onemocnění
Investor: Masaryk University, Category A
MUNI/A/1550/2018, interní kód MU
Name: Farmakologický výzkum v oblasti farmakokinetiky, neuropsychofarmakologie a onkologie
Investor: Masaryk University, Category A